Coherus BioSciences, Inc. (CHRS) financial statements (2020 and earlier)

Company profile

Business Address C/O DENNIS M. LANFEAR
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17172127125158150
Cash and cash equivalents16572127125158150
Short-term investments5     
Other undisclosed cash, cash equivalents, and short-term investments0     
Restricted cash and investments000000
Receivables90 1224
Inventory, net of allowances, customer advances and progress billings82    
Inventory82    
Prepaid expense 218323520
Other current assets 00332
Other undisclosed current assets98(1)  2
Total current assets:27684145161197179
Noncurrent Assets
Inventory, Noncurrent304    
Operating lease, right-of-use asset11
Property, plant and equipment671311114
Intangible assets, net (including goodwill)444444
Goodwill111111
Intangible assets, net (excluding goodwill)333333
Restricted cash and investments 1111 
Other noncurrent assets100200
Total noncurrent assets:51151717158
TOTAL ASSETS:32799163178212187
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities443325485023
Accounts payable14151520269
Accrued liabilities1679282411
Employee-related liabilities1311   3
Debt2     
Due to related parties     2
Business combination, contingent consideration, liability  3616
Deferred revenue and credits 15023
Other liabilities200000
Other undisclosed current liabilities35 025(2)
Total current liabilities:8333285610652
Noncurrent Liabilities
Long-term debt and lease obligation163777675  
Long-term debt, excluding current maturities152777675  
Operating lease, liability11
Liabilities, other than long-term debt262727284741
Deferred revenue and credits 14540
Due to related parties26262525  
Other liabilities 22220
Business combination, contingent consideration, liability00   1
Other undisclosed noncurrent liabilities    6628
Total noncurrent liabilities:18910510410311369
Total liabilities:271138132159219120
Stockholders' equity
Stockholders' equity attributable to parent56(39)3221(6)67
Common stock000000
Additional paid in capital991947808558404254
Accumulated other comprehensive loss(0)(0)(1)(1)(0)(1)
Accumulated deficit(934)(985)(775)(537)(410)(187)
Stockholders' equity attributable to noncontrolling interest  (1)(1)(1)(0)
Total stockholders' equity:56(39)3119(7)67
TOTAL LIABILITIES AND EQUITY:32799163178212187

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues232 21903031
Revenue, net21903031
Cost of revenue
(Cost of Goods and Services Sold)
(3)     
Gross profit:229 21903031
Operating expenses(230)(204)(234)(306)(249)(96)
Other undisclosed operating income3     
Operating income (loss):2(204)(232)(116)(219)(65)
Nonoperating income (expense)253(4)(5)(18)
Other nonoperating income (expense)253(4)(5)(19)
Interest and debt expense(16)(10)(10)(8)(0)(2)
Loss from continuing operations before income taxes:(11)(209)(238)(128)(224)(84)
Income tax expense(1)     
Loss before gain (loss) on sale of properties:(12)(209)(238)(128)(224)(84)
Other undisclosed net loss     (3)
Net loss:(12)(209)(238)(128)(224)(87)
Net income attributable to noncontrolling interest 00010
Net loss available to common stockholders, basic:(12)(209)(238)(127)(223)(87)
Interest on convertible debt2     
Net loss available to common stockholders, diluted:(10)(209)(238)(127)(223)(87)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(12)(209)(238)(128)(224)(87)
Other undisclosed comprehensive income (loss)(0)0(0)(0)0(1)
Comprehensive loss:(12)(209)(238)(128)(224)(88)
Comprehensive income, net of tax, attributable to noncontrolling interest 00010
Comprehensive loss, net of tax, attributable to parent:(12)(209)(238)(128)(223)(88)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: